Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
10.66
+0.03 (0.28%)
May 19, 2026, 4:00 PM EDT - Market closed
Bioventus Revenue
Bioventus had revenue of $132.09M in the quarter ending March 28, 2026, with 6.63% growth. This brings the company's revenue in the last twelve months to $576.30M, up 1.52% year-over-year. In the year 2025, Bioventus had annual revenue of $568.09M, down -0.91%.
Revenue (ttm)
$576.30M
Revenue Growth
+1.52%
P/S Ratio
1.55
Revenue / Employee
$613,085
Employees
940
Market Cap
890.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 568.09M | -5.19M | -0.91% |
| Dec 31, 2024 | 573.28M | 60.94M | 11.89% |
| Dec 31, 2023 | 512.35M | 228.00K | 0.04% |
| Dec 31, 2022 | 512.12M | 81.22M | 18.85% |
| Dec 31, 2021 | 430.90M | 109.74M | 34.17% |
| Dec 31, 2020 | 321.16M | -18.98M | -5.58% |
| Dec 31, 2019 | 340.14M | 20.96M | 6.57% |
| Dec 31, 2018 | 319.18M | 65.53M | 25.83% |
| Dec 31, 2015 | 253.65M | 10.76M | 4.43% |
| Dec 31, 2014 | 242.89M | 10.52M | 4.53% |
| Dec 31, 2013 | 232.38M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| QuidelOrtho | 2.66B |
| Integra LifeSciences Holdings | 1.64B |
| CONMED | 1.37B |
| Tandem Diabetes Care | 1.03B |
| Inspire Medical Systems | 915.25M |
| Avanos Medical | 715.90M |
| Artivion | 458.69M |
| InMode | 374.64M |
BVS News
- 12 days ago - Bioventus reports Q1 EPS 15c, consensus 7c - TheFly
- 12 days ago - Bioventus raises FY26 adjusted EPS view to 75c-79c from 73c-77c - TheFly
- 13 days ago - Bioventus Earnings Call Transcript: Q1 2026 - Transcripts
- 13 days ago - Bioventus Earnings release: Q1 2026 - Filings
- 13 days ago - Bioventus Quarterly report: Q1 2026 - Filings
- 13 days ago - Bioventus Slides: Q1 2026 - Filings
- 13 days ago - Bioventus Reports First Quarter Financial Results - GlobeNewsWire
- 21 days ago - Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026 - GlobeNewsWire